The groundbreaking therapy of tirzepatide peptide represents a exciting advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide257472.gynoblog.com/40773740/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment